Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.
Clicks: 412
ID: 1936
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
66.7
/100
412 views
321 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #19 of 78 articles by views in plos medicine
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
dooley2019advancingplos
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Dooley, Kelly E;Hanna, Debra;Mave, Vidya;Eisenach, Kathleen;Savic, Radojka M; |
| Journal | plos medicine |
| Year | 2019 |
| DOI |
10.1371/journal.pmed.1002842
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.